Skip to content

Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00873249
Acronym
SMS
Enrollment
339
Registered
2009-04-01
Start date
2009-04-30
Completion date
2010-03-31
Last updated
2010-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Schizophrenia, Therapeutic adherence, Short message system, Mobile phone

Brief summary

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patients older than 18 years * With a diagnosis of schizophrenia (DSM-IV TR criteria) * Stabilized out-patients * Under oral antipsychotic monotherapy

Exclusion criteria

* Administration of a depot antipsychotic drug * Suicide risk

Design outcomes

Primary

MeasureTime frame
Morisky Green Questionnairebaseline, at months 3 and 6

Secondary

MeasureTime frame
Clinical Global Impression- Schizophrenia (CGI-SCH)baseline, at months 3 and 6
Register of Adherence to Treatment (RAT)baseline, at months 3 and 6

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026